Recent advances have defined perspectives of metabolomic profiling of cancer that have defined treatment response, ‘stemness’, oxidative stress, changes with respect to the estrogen receptor (ER) status of breast cancer etc.17, 18, 19. This evidence concerns the gene ESR1 and breast cancer.